Development

INSIGHTS ON DRUG DEVELOPMENT

Column Selection For RPLC-UV Impurity Analysis
Explore the performance of four column chemistries for RPLC-UV impurity analysis of liraglutide and semaglutide, which offers practical guidance for method development in peptide-based therapeutics.
Softgel Formulation Strategies For Challenging Oral Compounds
Explore strategies to solve solubility and permeability challenges, boost oral bioavailability, and ensure consistent absorption — reducing risk and unlocking complex molecules.
Comprehensive And Streamlined Genomic Signature Assessment
Simultaneous analysis of HRD, TMB, and MSI offers a more complete view of tumor biology. A modular sequencing approach enables efficient workflows, conserves samples, and delivers deeper insights.
Maintain Control Of Pharmaceutical Water Systems
Early TOC excursions often reveal hidden risks in water systems. Capturing samples at the moment of deviation helps teams confirm root causes faster, reduce uncertainty, and maintain control.

Developing Non-PEG Stabilizer Lipids For Nucleic Acid Lipid Nanoparticles
7/1/2026

Non-PEG stabilizer lipids may offer a new path for LNP design. Combining strong colloidal performance with greater chemical flexibility helps address growing concerns around PEG-related immunogenicity.
Accelerate Your pDNA And mRNA Process Development
11/13/2025

Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.
3 Key Considerations In Gene Therapy Manufacturing
7/15/2025

Viral vector-based gene therapies are redefining medicine. As developers navigate uncharted territory, Sybil Danby of Cytiva highlights three critical areas shaping the journey from discovery to patient access.
Molecular Properties Of PROTACs And The Relationship To Formulation Design
3/4/2025

Here, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.
High-Throughput IgG Quantification Assay For Cell Line Development
4/4/2025

Monoclonal antibodies are revolutionizing treatment for various diseases, which include cancer and autoimmune disorders. Discover how improving production methods can reduce costs and enhance accessibility.

Empowering Biologics Development With HRMS Services

Examine ways to accelerate biologic development with high-resolution mass spectrometry services that deliver precise, reliable data from discovery through commercial release.
Microcalorimetry: RS-DSC, DSC & ITC

By harnessing cutting-edge microcalorimetry technology, researchers can unravel the complexities of molecular interactions, paving the way for groundbreaking discoveries in drug development.
Peptide Development Strategies

Peptides occupy a therapeutic niche between small molecules and large biologics. We understand the fundamental physiological challenges to peptide delivery and that there is no “one-size-fits-all” approach for formulation design.
Small is Powerful

Explore best-in-class nanoforming services and how this company works with partners to find ground-breaking solutions that enhance drug effectiveness and targeting.
Tailored Process Development Services Designed For Success

Explore the design services offered by the Gibco Media by Design team including cell line development, media and feed panel evaluations, bioproduction analytics and more.